Global L-Carnitine Market - 2021-2028
|出版日期||內容資訊||英文 180 Pages
|左旋肉鹼的全球市場(2021年∼2028年) Global L-Carnitine Market - 2021-2028|
|出版日期: 2021年08月06日||內容資訊: 英文 180 Pages||
L-carnitine is a natural compound synthesized from lysine and methionine, which is similar to the body amino acid. L-carnitine participates in the transformation of fats to energy, which helps in the treatment of carnitine deficiency. Moreover, carnitine deficiency develops long-chain fatty acids that are not available for B-oxidation or energy production, which causes excessive lipid accumulation in organs such as muscle. In addition, carnitine is also necessary to maintain the function and morphology of the brown adipose tissue. The global L-Carnitine market value is expected to reach US$ XX billion in 2028 from the recorded market size worth of US$ XX billion in 2020, growing at a CAGR of XX% during the forecast period (2021-2028).
Growing health concerns among geriatric population is driving the growth of the market
The growing geriatric population susceptible to various body disorders such as kidney, heart, and others is expected to boost the L-carnitine market's demand during the forecast period. L-carnitine plays a significant role in keeping up the requirements to produce energy in the body, as it is involved in carrying long-chain fatty acids to the mitochondria for energy production. Moreover, the extensive use of L-carnitine in treating carnitine deficiency in end-stage renal diseases resulting from dialysis has compounded L-carnitine consumption in the form of products. This product is used to treat carnitine deficiencies resulting from low carnitine absorption and chronic kidney failure.
Furthermore, increasing concerns regarding the quality and safety of meat have promoted the use of supplements in animal feed. The use of L-carnitine as a supplement in animal feed is likely to provide various benefits including growth performance and improved reproduction process. It is used in the feed of different domestic animals such as cows, pigeons, racing horses, and pigs to enhance their average gain rate and daily performance and growth. The expansion of the animal feed industry is likely to increase the demand for L-carnitine over the forecast period.
Technological advancements related to manufacturing techniques are projected to play a significant role in driving the market growth. Complexity in the manufacturing process and misleading advertisements promoting hyped product benefits are expected to hamper the market growth. The industry is also expected to face regulatory limitations due to the excessive amount of waste and wastewater created through the manufacturing processes.
Increasing the use of L-carnitine and its derivatives for animal feed is estimated to propel market growth
Feed grade is widely used as a key ingredient in animal feed and animal pharmaceuticals. It is an essential component for energy metabolism in animals and offers a wide range of benefits to various species including weight management and healthy function of heart and liver. It is also primarily used as a supplement for pets with heart disease, especially dilated cardiomyopathy in dogs. Moreover, it is used as an essential supplement for the treatment of obesity, hyperlipidemia, and diabetic ketoacidosis, which are conditions commonly found in cats and dogs. The product is preferred for the treatment of fatty liver syndrome in cats. In the case of cows, L-carnitine supplements are used to increase their rate of lactation. Also, oral administration of L-carnitine is advised for growing sheep to elevate plasm glucose concentrations. Consistent consumption of L-carnitine supplements has proven to have positive effects on growth performance, carcass composition, and breeding performance of pigs.
North America dominates the global L-carnitine market during the forecast period
The United States holds the largest share of the market in this region owing to the recommendation by medical professionals to individuals with genetic disorders whose bodies are unable to synthesize carnitine naturally. Moreover, the rising L-carnitine consumption to improve lean body mass in people is boosting the market's growth in this region. In addition, L-Carnitine's has significant benefits such as enhancing endurance, weight management, and promoting efficient conversion of food into energy are anticipated. This benefit is expected to drive L-carnitine consumption during the forecast period.
The global L-Carnitine market is highly competitive with some of the pioneers and new emerging players in the market. ChengDa PharmaCeuticals Co.,Ltd., HuangGang HuaYang Pharmaceutical Co., Ltd., Kaiyuan Hengtai Chemical Co., Ltd., Merck KGaA, Cayman Chemical, Northeast Pharmaceutical Group Co., Lonza, and Foodchem International Corporation are some of the key players in the L-carnitine market. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to growing the L-carnitine market globally. For instance, the Lonza Group launched a new formulation named under the brand MuscleGuard™ which is a combination Lonza's Carnipure®L-Carnitine, Creatine and Leucine with vitamin D. The solution is claimed to deliver effective results towards development in performance and recovery pf sport persons by increasing their muscle strength, mass and activity.
COVID-19 Impact: Pandemic had a positive impact on global L-carnitine market
As consumers are widely looking for immunity boosting ingredients, the demand for L-carnitine is expected to increase during the pandemic. Different studies showed that acetyl L-Carnitine (LC) positively affects the development and maturation of T lymphocytes, involved in the immune response to viral agents. It also contributes to the inhibition of ROS production and to the remodulation of the cytokine network typical of the systemic inflammatory syndrome. Researchers at the MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK, found that carnitine and its derivative acetyl-carnitine provide a protective effect against severe COVID-19. Doubling of carnitine or acetyl-carnitine is tied to a 40-percent reduction risk of disease progression. This is expected to influence the market positively.